ReversingCancer.org
News
Detecting Cancer @ Stage Negative 1 TODAY
By Perry Marshall
May 23, 2024 | 0 Comment
The Cancer Open Source Tissue Repository will spare patients from late-stage slash, poison and burn; it will save lives and prevent financial disaster. It will give deep new insights into the origins of cancer; and lead to treatments that find cancer before it finds us.
The Repository, founded by Dr. Azra Raza, solves FIVE problems at once:
- Detects cancer at Stage Negative One for the people at highest risk – cancer patients in remission.
- Gives doctors and patients the chance to pre-empt recurring cancer and treat it early – while it’s still manageable and inexpensive
- Pinpoints the earliest origin of first cancer cells
- Gives unprecedented data on early stage cancer (right now, 90% of cancer data is Stage 3 & 4) including anonymized patient history
- Makes this data available FREE instead of being locked in institutional silos
A group of blue-chip hospitals including Columbia, Harvard and Johns Hopkins has agreed to take blood, saliva, stool, urine, fingernail and hair samples from cancer patients in remission, every time they come back for checkups.
This video by Perry Marshall explains the project, which has already begun at Columbia University in New York City:
The ReversingCancer newsletter describes the project in detail.
Click here to donate to this world-changing project.Download The First 3 Chapters of Evolution 2.0 For Free, Here – https://evo2.org/evolution/
Where Did Life And The Genetic Code Come From? Can The Answer Build Superior AI? The #1 Mystery In Science Now Has A $10 Million Prize. Learn More About It, Here – https://www.herox.com/evolution2.0
Perry Marshall
NASA Jet Propulsion Labs uses his 80/20 Curve as a productivity tool. His reinvention of the Pareto Principle is published in Harvard Business Review. His Ultimate Guide to Google Ads is the best-selling book on internet advertising.
A business strategist and electrical engineer, Perry founded the largest science research award in history. The $10 million Evolution 2.0 Prize will be judged by scientists from Harvard, Oxford, and MIT. Seeing that existing financial incentives favor prolonging cancer rather than curing it; and realizing the medical profession has incorrectly defined the disease in the first place... he chose to apply entrepreneurial thinking to the problem.
